Novartis AG Current Refunds Provision
Novartis AG (NVSEF) had Current Refunds Provision of $7.81 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CurrentRefundsProvision · last filed 2026-02-04
- 2025-12-31: Current Refunds Provision $7.81B.
- 2024-12-31: Current Refunds Provision $7.00B.
- 2023-12-31: Current Refunds Provision $6.32B.
- 2022-12-31: Current Refunds Provision $6.73B.
| Period end | Current Refunds Provision |
|---|---|
| 2025-12-31 | $7.81B 20-F · filed 2026-02-04 |
| 2024-12-31 | $7.00B 20-F · filed 2026-02-04 |
| 2023-12-31 | $6.32B 20-F · filed 2026-02-04 |
| 2022-12-31 | $6.73B 20-F · filed 2026-02-04 |
| 2021-12-31 | $6.48B 20-F · filed 2025-01-31 |
| 2020-12-31 | $6.26B 20-F · filed 2024-01-31 |
| 2019-12-31 | $5.59B 20-F/A · filed 2023-05-15 |
| 2018-12-31 | $5.26B 20-F · filed 2022-02-02 |
| 2017-12-31 | $4.67B 20-F · filed 2021-01-26 |
| 2016-12-31 | $4.18B 20-F · filed 2020-01-29 |